OrthoCentrum Hamburg
- Address
- Hansastr. 1-3, 20149 Hamburg, Germany
OrthoCentrum Hamburg - Tendon Injury Research
OrthoCentrum Hamburg is a specialized orthopedic research center dedicated to advancing the treatment of musculoskeletal conditions through innovative clinical trials. The center focuses on evaluating novel therapeutic approaches for tendon disorders and sports-related injuries, with particular expertise in lower extremity pathologies.
- Achilles tendinopathy treatment development
- Novel regenerative medicine applications for tendon healing
- Safety and efficacy evaluation of innovative microparticle-based therapies
The center's research program emphasizes peritendon injection techniques and the assessment of both local and systemic safety profiles of experimental therapeutics. Through rigorous clinical investigation, OrthoCentrum Hamburg contributes to the development of next-generation treatments for mid-portion Achilles tendinopathy, addressing a common condition that affects athletes and active individuals worldwide.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in OrthoCentrum Hamburg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A two part, randomized, participant and investigator-blinded, 2-arm, parallel-design, placebo-controlled study to evaluate the safety, tolerability and preliminary efficacy of NGI226 microparticles on tendon regeneration in patients with Achilles tendinopathy | Novartis Pharma AG | Phase II | Not Recruiting | Oct 2023 | Feb 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ngi226 | 1 | Unknown | 2023-10-18 | 2023-10-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.